Thierry Tordjmann, Laurent Combettes, Michel Claret – 30 December 2003

30 December 2003

Shuichi Okada, Toshiya Sato, Seiichiro Yamamoto – 30 December 2003

30 December 2003

Adrian Reuben – 30 December 2003

Neil Kaplowitz – 30 December 2003

Neil Kaplowitz – 30 December 2003

Priya Sampathkumar, Amir Lerman, Barbara Youngmee Kim, Bradley J. Narr, John J. Poterucha, Laurence C. Torsher, David J. Plevak – 30 December 2003 – Patients with end‐stage liver disease usually show a hyperdynamic circulatory state. It has previously been reported that patients who develop myocardial depression in the early post–liver transplantation period are more prone to organ failure and death.

Emmet B. Keeffe, David S. Krause – 30 December 2003

Anderson S. Gaweco, Russell H. Wiesner, Sherri Yong, Ruud Krom, Michael Porayko, Gregorio Chejfec, Kenneth D. McClatchey – 30 December 2003 – The CD40‐CD40L (CD154) interaction plays a pivotal role in the effector mechanisms of allograft rejection. Blockade of the CD40/CD40L costimulatory pathway prevents the development of chronic allograft rejection in several animal transplant models. The relevance of in situ CD40 and CD40L expression in human liver allografts was assessed by immunohistochemistry during ductopenic chronic rejection (CR).